DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Narlaprevir
Narlaprevir
HCV Protease
Direct-Acting Antiviral Medications for Chronic Hepatitis C Virus Infection
PI Narlaprevir in Russian Patients with Genotype 1 Chronic Hepatitis C
Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize With
Curing Hepatitis C" by Gregory T
13. Approved and Experimental Therapies
Structural Basis for the Inhibition of the SARS-Cov-2 Main Protease by the Anti-HCV Drug Narlaprevir
Tetrazolones As Inhibitors of Fatty Acid Synthase Tetrazolone Als Fettsäuresynthasehemmer Tétrazolones Utilisés En Tant Qu’Inhibiteurs D’Acide Gras Synthase (Fasn)
DRAFT: Targeting SARS-Cov-2 M3clpro by HCV Ns3a/4 Inhibitors: in Silico Modeling and in Vitro Screening
Repurposing of FDA Approved Drugs
Criteria Grid Best Practices and Interventions for the Diagnosis and Treatment of Hepatitis C
New Treatment Approaches and Cure Strategies
CER 76: Treatment for Hepatitis C Virus Infection in Adults
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-Cov-2 in Vitro
Drug Resistance Against HCV NS3/4A Inhibitors Is Defined by the Balance of Substrate Recognition Versus Inhibitor Binding
Approved Antiviral Drugs Over the Past 50 Years
Emerging Therapeutic Options in Hepatitis C Virus Infection
Understanding Drug Resistance and Antibody Neutralization Escape in Antivirals: a Dissertation
Top View
Antiviral Activity and Pharmacokinetics of a Novel HCV Protease Inhibitor Narlaprevir
CJ05013019 Protocol Version 8 20 Feb2017 Eng Final
Pegylated Interferon
Boceprevir, GC-376, and Calpain Inhibitors II, XII Inhibit SARS-Cov-2 Viral Replication by Targeting the Viral Main Protease
202258Orig1s000
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Working Minutes of the Ephmra Classification Committee
Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success
A Drug Repurposing Screen Identifies Hepatitis C Antivirals As Inhibitors of the SARS-Cov-2 Main 2 Protease
Remdesivir from Wikipedia, the Free Encyclopedia
Hepatitis C Virus NS3/4A Protease Inhibitors: a Light at the End of the Tunnel
HCV – STAT-C Era of Therapy Christian Markus Lange, Christoph Sarrazin, Stefan Zeuzem
Hepatitis C Virus: Structural Insights Into Protease Inhibitor Efficacy and Drug Resistance: a Dissertation
Repositioning of 8565 Existing Drugs for COVID-19
Supplemental Table 1: Inclusion and Exclusion Criteria
Rational Design of a New Class of Protease Inhibitors for the Potential Treatment of Coronavirus Diseases